Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
RESEARCH TOOLSreports
Holding ARWR?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | $ 3.55M | $ 16.10M | $ 15.82M |
| Gross Profit | - | - | $ 3.55M | $ 16.10M | $ 15.82M |
| EBIT | $ -168.88M | $ -119.75M | $ -133.32M | $ -103.73M | $ -98.22M |
| EBITDA | $ -164.10M | $ -115.23M | $ -129.06M | $ -99.87M | $ -94.95M |
| Net Income Common Stockholders | $ -165.70M | $ -125.30M | $ -132.88M | $ -109.68M | $ -97.79M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 367.27M | $ 395.41M | $ 162.06M | $ 292.74M | $ 346.37M |
| Total Assets | $ 883.76M | $ 955.15M | $ 626.29M | $ 765.55M | $ 795.86M |
| Total Debt | $ 118.09M | $ 118.92M | $ 118.58M | $ 115.17M | $ 82.73M |
| Net Debt | $ -249.18M | $ -276.49M | $ -43.49M | $ -177.56M | $ -263.63M |
| Total Liabilities | $ 544.78M | $ 459.75M | $ 452.57M | $ 478.39M | $ 413.87M |
| Stockholders Equity | $ 330.55M | $ 483.79M | $ 160.41M | $ 271.34M | $ 364.83M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -129.87M | $ -126.45M | $ -186.50M | $ -89.16M | $ -67.38M |
| Operating Cash Flow | $ -115.42M | $ -92.38M | $ -117.84M | $ -25.26M | $ -20.78M |
| Investing Cash Flow | $ 6.95M | $ -268.94M | $ 64.84M | $ 30.51M | $ -9.90M |
| Financing Cash Flow | $ 50.39M | $ 430.78M | $ 267.00K | $ 152.00K | $ 1.14M |